Elevated TANGO expression levels were detected in 10 of 30 head and neck SCCs (33.3%), 3 of 10 ESCCs (30%), 8 of 35 colorectal adenocarcinomas (22.9%), 1 of 5 pancreatic adenocarcinomas (20%), 6 of 18 lung SCCs (33.3%), 2 of 10 cutaneous malignant melanomas (20%), 1 of 3 cutaneous SCCs (33.3%), 3 of 7 mammary invasive ductal carcinomas (32.9%), 7 of 21 cervical SCCs (33.3%), 3 of 11 endometrial endometrioid adenocarcinomas (27.3%) (Figure 1G), 2 of 6 prostatic adenocarcinomas (33.3%), 2 of 8 testicular seminomas (25%), and 4 of 12 papillary thyroid carcinomas (33.3%) (Figure 1I). Here, MIA3 is linked to prostate adenocarcinoma.